🔎 Trials Near Me

홈 › 만성 골수성 백혈병 › 텍사스

텍사스의 만성 골수성 백혈병 임상 시험

만성 골수성 백혈병 관련 연구 18개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

  • M D Anderson Cancer Center, Houston
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT02115295

Asciminib Roll-over Study

  • Texas Oncology, Dallas
  • Uni Of TX MD Anderson Cancer Cntr, Houston
피험자 모집 중4상
7세 ~ 100세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT04877522

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • UT MD Anderson Cancer Center, Houston
  • Audie L Murphy VA Hospital, San Antonio
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

  • MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06236724

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Texas Children's Hospital, Houston
피험자 모집 중관찰 연구
0세 ~ 38세 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06131801

TGRX-678 US Phase I for Chronic Myelogenous Leukemia Patients

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06088888

A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)

  • The University of Texas M.D. Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT06163430

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

  • The University of Texas M. D. Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07269470

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

  • University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT00816114

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib

  • MD Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06817720

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

  • M D Anderson Cancer Center, Houston
피험자 모집 중1상
1세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT03630991

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

  • M D Anderson Cancer Center, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT01746836

Study of Olverembatinib (HQP1351) in Patients With CML-CP

  • Ascentage Investigative Site #1051, Amarillo
  • Ascentage Investigative Site #1036, Austin
  • Ascentage Investigative Site #1501, Houston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06423911

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Medical City Dallas, Dallas
  • Children's Medical Center Dallas, Dallas
  • Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
  • 외 5개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 1. 업데이트됨 · NCT05304377

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • MD Anderson, Houston
피험자 모집 중2상
18세 ~ 66세 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06859424

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

  • MD Anderson Cancer Center, Houston
피험자 모집 중1상
12세 이상 · 모든 성별 · 2026. 3. 16. 업데이트됨 · NCT06994676

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

  • University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 11. 5. 업데이트됨 · NCT04260022

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.